Why the study?
Does ranolazine prevent left ventricular hypertrophy and t-tubule disruption in a rat model of hypertensive heart disease?
Population
Male Spontaneously Hypertensive Rats, aged 7 months.
Comparison
Ranolazine 0.5% in chow for 3 months. vs Normal control chow for 3 months.
Design
Preclinical
Follow-up
3 months
Authors
Loading...
Hypothesis-generating for late Na current inhibition in hypertensive LVH models; human trials needed before clinical consideration.
Does ranolazine prevent left ventricular hypertrophy and t-tubule disruption in a rat model of hypertensive heart disease?
Chronic inhibition of the late sodium current with ranolazine slows the progression of left ventricular hypertrophy and prevents ultrastructural and physiological calcium cycling defects in a rat model of hypertensive heart disease.
Aistrup et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: